Product ID: SQMIG30I2309
Report ID:
SQMIG30I2309 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
65 |
Figures:
75
The human milk oligosaccharides (HMO) market showed notable regional variations, with North America having the largest market share. North America's advanced baby feeding business, robust research capacity, and increasing consumer demand for HMO-fortified goods are the reasons for its dominance. The notable use of HMOs in infant formula and related products can be attributed to the region's focus on ensuring optimal infant health and development.
Europe is now the second-biggest market for HMOs, after North America. Similar emphasis on infant health and nourishment, along with a pro-active regulatory structure that encourages the entry of new ingredients into the food and beverage industry, are advantageous for the European market. The use of HMOs in baby formula and other applications has been further supported by European consumers' preference for useful and health-improving products.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG30I2309